Clinical Trial Update: ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ctDNA-guided therapy for adults with relapsed or refractory Hodgkin lymphoma; the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Michael Spinner, MD | Conditions: Hodgkin Lymphoma, Adult, Refractory Hodgkin Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING